GMAB Stock Tickeron detected bearish Stock Pattern: Broadening Bottom GMAB on November 13, 2024, netting in a 7.57% gain over 1 month

GET DAILY SIGNALS

Get AI intraday signals

GMAB - Genmab A/S ADS

Ticker: GMAB

Company: Genmab A/S ADS

Gain from shortening: +7.57%

Confirmed: 11/13/24

Succeeded: 12/16/24

Total length: 33 days

GMAB's Stochastic Oscillator is staying in overbought zone for 6 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

GMAB broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 27, 2024. You may want to consider a long position or call options on GMAB as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GMAB just turned positive on December 26, 2024. Looking at past instances where GMAB's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

GMAB moved above its 50-day moving average on January 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GMAB advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GMAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.998) is normal, around the industry mean (14.746). P/E Ratio (20.825) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.754) is also within normal values, averaging (1.853). GMAB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (4.943) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.